Breaking News
Sort by:
Top Post
Roche’s Tecentriq Plus Avastin Reduced Risk of Cancer Returning in People with Certain Types of Adjuvant Liver Cancer in a Phase III Study
Roche has announced new data from the Phase III IMbrave050 study that show Tecentriq (atezolizumab) […]
Ginkgo Bioworks and WARF Announce Partnership to Discover Next Generation GD2 CAR T-Cell Therapies
The Wisconsin Alumni Research Foundation (WARF), which has a mission of supporting research at the University […]
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Geneos Therapeutics Secures $5 Million in Series A3 Financing
Geneos Therapeutics, a clinical-stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines […]
Junshi Biosciences Announces Phase 3 Clinical Study of Senaparib for Advanced Ovarian Cancer Maintenance Treatment
Shanghai Junshi Biosciences (TopAlliance), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and […]
Ultima Genomics and Genome Insight Collaborate to Bring Affordable Whole Genome Sequencing to Cancer Patients
Ultima Genomics and Genome Insight have signed an agreement to collaborate to bring affordable whole […]
Life-Saving NHS Test Helping To Diagnose Thousands With Cancer-Causing Syndrome
A life-saving NHS testing programme is helping to diagnose thousands of people with a genetic […]
MOLLI Surgical Launches Breakthrough Products to Simplify Breast Cancer Surgery and Deliver a Better Patient Experience
MOLLI Surgical, the company that is pushing the boundaries of precision surgery for breast cancer, […]
Personalis Joins Top UK Cancer Research Organizations to Evaluate Earlier Cancer Recurrence Detection Through Groundbreaking Study
Personalis, Cancer Research UK’s Cancer Research Horizons, University College London (UCL), and the Francis Crick […]
Scorpion Therapeutics and Pierre Fabre Announce Collaboration and License Agreement to Co-Develop and Commercialize STX-721 and STX-241 for Patients with Non-Small Cell Lung Cancer
Scorpion Therapeutics, a pioneering oncology company redefining the frontier of precision medicine through its Precision […]
iNtRON Confirms Cancer-Controlling Effect of PHAGERIA® Drug Candidate in the Organoid Model
iNtRON Biotechnology has announced today that iNtRON has demonstrated the effectiveness of P18-BE3CRC using a […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more